| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥81.42B | ¥85.64B | -4.9% |
| Cost of Sales | ¥51.80B | ¥54.68B | -5.3% |
| Gross Profit | ¥29.63B | ¥30.97B | -4.3% |
| SG&A Expenses | ¥25.61B | ¥26.70B | -4.1% |
| Operating Income | ¥4.01B | ¥4.27B | -6.0% |
| Non-operating Income | ¥1.39B | ¥1.41B | -1.4% |
| Non-operating Expenses | ¥371M | ¥234M | +58.5% |
| Ordinary Income | ¥5.03B | ¥5.45B | -7.6% |
| Profit Before Tax | ¥2.15B | ¥4.79B | -55.0% |
| Income Tax Expense | ¥1.91B | ¥2.49B | -23.1% |
| Net Income | ¥241M | ¥2.30B | -89.5% |
| Net Income Attributable to Owners | ¥240M | ¥2.30B | -89.6% |
| Total Comprehensive Income | ¥4.44B | ¥-4.02B | +210.4% |
| Depreciation & Amortization | ¥3.99B | ¥3.66B | +8.9% |
| Interest Expense | ¥147M | ¥156M | -5.8% |
| Basic EPS | ¥2.77 | ¥22.95 | -87.9% |
| Dividend Per Share | ¥70.00 | ¥70.00 | +0.0% |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥188.34B | ¥186.56B | +¥1.78B |
| Cash and Deposits | ¥69.91B | ¥61.35B | +¥8.56B |
| Accounts Receivable | ¥34.62B | ¥40.32B | ¥-5.70B |
| Inventories | ¥29.32B | ¥30.42B | ¥-1.10B |
| Non-current Assets | ¥113.20B | ¥110.74B | +¥2.45B |
| Item | Current | Prior | Change |
|---|---|---|---|
| Operating Cash Flow | ¥8.32B | ¥7.27B | +¥1.05B |
| Investing Cash Flow | ¥-2.66B | ¥-6.78B | +¥4.12B |
| Financing Cash Flow | ¥779M | ¥-5.72B | +¥6.50B |
| Free Cash Flow | ¥5.66B | - | - |
| Item | Value |
|---|---|
| Net Profit Margin | 0.3% |
| Gross Profit Margin | 36.4% |
| Current Ratio | 251.3% |
| Quick Ratio | 212.1% |
| Debt-to-Equity Ratio | 0.60x |
| Interest Coverage Ratio | 27.31x |
| EBITDA Margin | 9.8% |
| Effective Tax Rate | 88.8% |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | -4.9% |
| Operating Income YoY Change | -6.0% |
| Ordinary Income YoY Change | -7.6% |
| Net Income Attributable to Owners YoY Change | -89.6% |
| Item | Value |
|---|---|
| Shares Outstanding (incl. Treasury) | 92.50M shares |
| Treasury Stock | 9.10M shares |
| Average Shares Outstanding | 86.90M shares |
| Book Value Per Share | ¥2,262.16 |
| EBITDA | ¥8.00B |
| Item | Amount |
|---|---|
| Year-End Dividend | ¥70.00 |
| Segment | Revenue | Operating Income |
|---|---|---|
| IndustrialProcesses | ¥34.43B | ¥2.05B |
| LifeSciences | ¥3.29B | ¥169M |
| PhotonicsSolutions | ¥4.98B | ¥85M |
| VisualImaging | ¥38.08B | ¥1.80B |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥170.00B |
| Operating Income Forecast | ¥10.00B |
| Ordinary Income Forecast | ¥10.50B |
| Net Income Attributable to Owners Forecast | ¥7.00B |
| Basic EPS Forecast | ¥79.45 |
| Dividend Per Share Forecast | ¥70.00 |
| Property, Plant & Equipment | ¥50.28B | ¥49.92B | +¥369M |
| Intangible Assets | ¥4.75B | ¥5.11B | ¥-353M |
| Goodwill | ¥580M | ¥635M | ¥-55M |
| Investment Securities | ¥39.93B | ¥37.47B | +¥2.46B |
| Total Assets | ¥301.54B | ¥297.30B | +¥4.23B |
| Current Liabilities | ¥74.96B | ¥51.40B | +¥23.56B |
| Accounts Payable | ¥15.86B | ¥15.27B | +¥589M |
| Short-term Loans | ¥1.75B | ¥1.62B | +¥131M |
| Non-current Liabilities | ¥37.91B | ¥45.40B | ¥-7.49B |
| Long-term Loans | ¥26.50B | ¥35.00B | ¥-8.50B |
| Total Liabilities | ¥112.86B | ¥96.79B | +¥16.07B |
| Total Equity | ¥188.67B | ¥200.51B | ¥-11.84B |
| Capital Stock | ¥19.56B | ¥19.56B | ¥0 |
| Capital Surplus | ¥27.77B | ¥27.77B | ¥0 |
| Retained Earnings | ¥105.79B | ¥111.78B | ¥-5.99B |
| Treasury Stock | ¥-17.72B | ¥-7.67B | ¥-10.05B |
| Owners' Equity | ¥188.66B | ¥200.50B | ¥-11.84B |
| Working Capital | ¥113.38B | - | - |